Pharmasyntez showed the guest round new manufacturing department No. 5 launched in early 2021 where broad spectrum drug products for the treatment of infectious diseases are manufactured.
The minister was also shown how antivirals are produced at the sterile dosage form area where, in particular, Remdeform (INN Remdesivir), the drug for the treatment of the new coronavirus disease, is manufactured. The Irkutsk plant of Pharmasyntez is the only manufacturer of Remdesivir in Russia. It is this plant that supplies the drug to all healthcare institutions of Russia.
Vikram Punia, President of the Pharmasyntez Group of Companies, said at the meeting that the company would hold the course on the development and manufacture of innovative drugs in the next five years.
The minister was pleased with the visit results and noted that Pharmasyntez was a reliable partner of the Russian healthcare system, promptly providing the domestic market with high quality and efficient drug products.